Can an IVF Clinic Still Pay Its Agency Per Lead? What the NMC's October 2026 Notice Says
Verdict first, evidence later. Paying only for leads was never the safe way to approach IVF marketing. The NMC's 06th October 2026 notice just made the reason impossible to ignore.
I am Boudhhayan Duttaa, founder of Batti Jalao, a Guwahati-based healthcare marketing consultancy. Many IVF clinic owners have asked us whether paying an agency per lead is still safe after the NMC's 06th October 2026 notice. I read clauses 8.1(vii) and 8.1(viii) as a marketer and this article sets-out what they say, what they leave open and what you can measure instead. It is not legal advice and your counsel should decide the fee structure.
So let us put the per-lead contract on trial. While this model feels safe, it's actually not. Three questions, one exhibit and a verdict lets you compute that for yourself.
What do clauses 8.1(vii) and 8.1(viii) say?
Lead fees and pay tied to procuring patients
Clause 8.1(vii) bars commissions, rebates, referral fees and lead fees tied to referring patients. Clause 8.1(viii) says contracts with agencies, marketers, influencers or platforms must not link payment to procuring or referring individual patients. Both come from the notice published on 6 October 2026 (S01) and trade press reported the same points the next day (S02).
Using an agency does not shift responsibility (4.4)
Clause 4.4 says content the doctor or institution authorised, sponsored or knowingly allowed stays theirs, whoever produced it. Hospitals are reached through the 'Clinical Establishments Act' or the state law (4.3). If you sign it, you own it.
What the notice does not say, in our reading, is whether a per-enquiry fee, a fee tied to a cost-per-qualified-lead target or a performance retainer sits inside those clauses. That is a question for your counsel and nobody should pretend the answer is obvious.
Why was 'Pay only for leads' never as safe as it looked?
Here is Exhibit A, with illustrative numbers. An IVF clinic pays its agency Rs 500 for every lead. The agency delivers 400 leads, so the clinic pays Rs.2,00,000. Cost per lead (CPL) is Rs.500. The agency's report looks wonderful.
Now count what the clinic's desk counts. A qualified lead is someone who matches your patient profile and shows real intent. Say 80 of the 400 are qualified and 40 become patients.
Same spend, three numbers and a 10x gap between the first and the last. A per-lead contract rewards the agency for the cheapest number on that list, which is also the least useful one. The risk was never only regulatory. It was always that the fee measured the wrong thing. (All figures are illustrative)
Why is attribution so hard in IVF?
Marketers who work with fertility clinics tell us that couples research for weeks or months, across search, forums, family conversations and several clinics before one call. That is a practitioner observation, not a measured statistic, so treat it as a reason for caution, not a number.
It matters for contracts because a single last-click figure credits whichever touch came last. A multi-touch attribution model spreads credit across the journey, but it needs clean source data in your own CRM and it still cannot tell you why a couple chose you. Report CPQL and CAC as ranges, month by month and write down your own definition of 'Qualified' before anyone reads the report.
Which fee models should your counsel compare?
Three shapes, all illustrative and all on the same Rs.2,00,000 of monthly spend. We list them so you can lay them side by side for counsel, not to recommend one.
Do not relabel Model A as Model B or C on paper. Your legal counsel needs to see how the money actually moves. The decision belongs to the clinic owner and its CFO, while the counsel reviews the wording.
How do CAC and CPQL work and what do they not tell you?
CAC is spend divided by new patients. CPQL is the spend divided by qualified leads. Both are plain division and the free Batti Jalao calculators do exactly that.
What they don't tell you is whether a patient was well served, whether the lead was ever reachable or which touch mattered. They are a measurement, not a fee basis. The calculators also print a comment on each result. Treat it as a prompt, not a benchmark.
What should an agency contract contain instead?
A fee that does not move with leads, enquiries, bookings or patients (confirm with counsel).
Reporting that shows spend, qualified leads and patients on separate lines.
Your definition of 'Qualified', written into the scope.
A named clinic approver for every piece of content, with a record of who approved and when (4.4).
No success-rate or superiority claims in any copy the agency drafts (8.1(iii)).
Where AI helps, with a human in charge:
BattiLynk AI drafts educational content for each stage of the IVF journey, for example "What to ask at a first IVF consultation", etc. A clinician reviews every draft.
BattiSense drafts the FAQs and schema from the questions couples ask at each stage. Pair them with a source field in your CRM, so the FAQ-led visits can be counted.
For an outside view, the free BattiAudit is one scan with three findings. Finding 3 covers paid-ads exposure and opportunity cost. BattiAudit Pro includes a 'Funnel and Patient-Journey Teardown' and a 'Lead-Response Audit', where the auditor makes a genuine enquiry, so no patient-data is involved.
None of it is an NMC compliance check or a legal opinion.
What should you do next?
Pull the agency contract and the last three invoices.
Highlight every fee that moves with leads, enquiries, bookings or patients.
Compute CPQL and CAC from your own books. Write down your definition of 'Qualified'.
Take three questions to your counsel: A per-enquiry fee, a retainer with a target and who approves content (4.4).
Write down who decided what and when.
Want the contract checklist?
DM 'CONTRACT' we will send the one-page agency-contract clause checklist. You can also try our free calculators first: https://www.battijalao.co/cpql-tool
Sources: National Medical Commission, Guidelines on Ethical Advertising and Public Communication, Notice No. R-13014/01/2024-Ethics, 6 October 2026; Medical Dialogues, 7 October 2026; Batti Jalao calculators, read 24 October 2026. Readings are paraphrased and are a marketer's reading, not legal advice.
